This study is in progress, not accepting new patients
SARS-CoV-2 Immune Responses After COVID-19 Therapy and Subsequent Vaccine
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Healthy Volunteers
- healthy people welcome
- Location
- at UCLA
- Dates
- study startedestimated completion
- Principal Investigator
- by David Smith, MD, MAS (ucsd)
Description
Summary
Details
Keywords
Eligibility
Locations
Lead Scientist at University of California Health
- David Smith, MD, MAS (ucsd)
Davey Smith, MD, MAS, is an infectious disease specialist and translational research virologist. In his translational research, he uses basic science techniques to answer clinically relevant questions. Dr. Smith's primary research involves both figuring out how to stop the transmission of HIV and curing HIV, and he has published over 200 scientific publications in these areas.
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- ID
- NCT04952402
- Phase
- Phase 4 research study
- Study Type
- Interventional
- Participants
- About 700 people participating
- Last Updated